ENTA Operating Income Growth
Enanta Pharmaceuticals Inc · Operating Income Growth
ENTA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported8.77%period ending
ENTA Quarterly Operating Income YoY % (-0.92% → 8.77%)
Year-over-year change
High-resolution chart · PNG
ENTA operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 8.7704% | |
| 51.6777% | |
| 52.2024% | |
| 38.4136% | |
| 21.8813% | |
| 25.145% | |
| 32.5145% | |
| 3.7899% | |
| 34.1242% | |
| 16.9451% | |
| -16.2363% | |
| -14.722% | |
| -12.8242% | |
| -16.5569% | |
| 1.3022% | |
| 19.8031% | |
| 3.8615% | |
| -13.963% | |
| -147.2477% | |
| -70.4848% | |
| -48.114% | |
| -150.1053% | |
| -195.5559% | |
| -407.6193% | |
| -708.5752% | |
| -810.6595% | |
| -53.7945% | |
| -81.3334% | |
| -83.4143% | |
| -107.7347% | |
| 93.7539% | |
| -36.5466% | |
| 272.4427% | |
| 277.3511% | |
| 304.0448% | |
| 1,852.0168% | |
| -1,105.6015% | |
| -1,582.4779% | |
| -119.7955% | |
| -184.3495% | |
| -163.946% | |
| -101.1635% | |
| -49.3035% | |
| 168.9824% | |
| -95.1196% | |
| 1,047.1621% | |
| 1,386.6044% | |
| -13.295% | |
| 935.2082% | |
| -28.143% | |
| -124.9076% | |
| -12.7609% | |
| -18.424% | |
| -112.4661% | |
| 788.5292% | |
| -0.9199% |